Download
|
< Back |
| 20 Oct 2011 | |
| Biocon Ltd has informed BSE regarding a regarding a Press Release dated October 19, 2011, titled "Biocon Posts a Strong 17% YOY Growth in Revenues in H1FY12, Launches Insulin Delivery Device INSUPen, Revenues at Rs 978 Crores; EBITDA at Rs 282 Crores; PAT at Rs 156 Crores" | |
| View all announcements for BIOCON LTD. | Source: BSE India |